Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (12), the stock would be worth R$16.82 (22% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.8 | R$13.74 |
0%
|
| 3-Year Average | 12 | R$16.82 |
+22%
|
| 5-Year Average | 14.5 | R$20.22 |
+47%
|
| Industry Average | 7.5 | R$10.49 |
-24%
|
| Country Average | 8.3 | R$11.56 |
-16%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
R$2.9B
|
/ |
Jan 2026
R$286.1m
|
= |
|
|
R$2.9B
|
/ |
Dec 2026
R$314.2m
|
= |
|
|
R$2.9B
|
/ |
Dec 2028
R$354.4m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| BR |
|
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
|
2B BRL | 9.8 | 16.6 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
62.7B ZAR | 13.3 | 19.4 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
31.3B ZAR | 16 | 25.3 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 5.1 | -1.6 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
38.5B BRL | 17.1 | 30.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
929.3B JPY | 14 | 21.8 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
911.6B JPY | 9.6 | 16.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 19 | 20.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29.2B CNY | 10 | 16.9 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 15.3 | 34.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
574.6B JPY | 11.4 | 12.8 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 6.8 |
| Median | 8.3 |
| 70th Percentile | 11.3 |
| Max | 288 |
Other Multiples
Dimed SA Distribuidora de Medicamentos
Glance View
Dimed SA Distribuidora de Medicamentos engages in the marketing, distribution and sale of medicines and cosmetics. The company is headquartered in Eldorado Do Sul, Rio Grande Do Sul and currently employs 9,414 full-time employees. The Company, along with its subsidiaries, sells, distributes, imports, exports and produces a variety of products, including drugs, perfumes, cosmetics, dermo-cosmetics, personal care products, dietary supplements, and fitness, orthopedic and physiotherapy accessories. The company organizes its business into two main segments: Medicine and Perfumery. The firm provides retail and wholesale distribution. The firm owns distribution centers in Brazilian states of Rio Grande do Sul, Santa Catarina, Parana, Goias and Espirito Santo, as well as over 280 stores in states of Rio Grande do Sul, Santa Catarina and Parana.
